文献速递临床微生物分子诊断

冰岛儿童接种10价肺炎球菌疫苗对成人产生显著群体效应

Vaccination of Icelandic Children with the 10-Valent Pneumococcal Vaccine Leads to a Significant Herd Effect among Adults in Iceland.
PubMed 文献 · J Clin Microbiol · 2019-03-28

研究分析了2009至2017年冰岛成人下呼吸道分离的肺炎球菌(n=797),评估2011年儿童接种10价肺炎球菌结合疫苗(PCV)后的群体效应。结果显示疫苗型(VT)肺炎球菌显著减少,但非疫苗型(NVT)在18-64岁成人中增加,且部分血清型(19F、6C)及非荚膜肺炎球菌多为多重耐药。

要点

  • 儿童接种10价PCV后成人VT肺炎球菌显著下降,显示群体效应。
  • 18-64岁成人NVT肺炎球菌增加,以6C和NESp为主且多耐药。
  • 19F血清型(台湾19F-14克隆)减少但均为多重耐药。

核心结论

  • 儿童接种10价PCV后4年内成人下呼吸道肺炎球菌总分离株和VT株显著减少,表明存在显著群体效应。
  • 但同时NVT肺炎球菌在18-64岁成人中增加,且部分血清型(6C、19F)和非荚膜菌株多为多重耐药。

研究设计与样本

  • 回顾性分析2009-2017年冰岛Landspitali大学医院成人下呼吸道分离的肺炎球菌(n=797),该医院服务全国近四分之三人口。
  • 对2009-2014年间每隔一株分离株进行全基因组测序(n=275),提取血清型和多位点序列分型。
  • 研究分为三个时期:2009-2011(PreVac)、2012-2014(PostVac-I)和2015-2017(PostVac-II)。

主要发现

  • 分离株总数从PreVac的314株降至PostVac-II的230株(p=0.002),VT肺炎球菌从170株降至33株(p<0.001)。
  • 18-64岁成人中NVT肺炎球菌从56株增至114株(p=0.008)。
  • 血清型19F在PostVac-II期减少,均为多重耐药且属于Taiwan19F-14 PMEN克隆。
  • ≥65岁成人中血清型6A减少(p=0.037),而6C增加(p=0.021),多数6C为多重耐药。
  • 18-64岁成人中非荚膜肺炎球菌(NESp)增加,多数为多重耐药(p=0.028)。

临床怎么用

  • 监测儿童PCV接种后成人肺炎球菌血清型分布变化,关注NVT和耐药菌株的替代。
  • 对成人下呼吸道感染经验性治疗时需考虑NVT和多重耐药菌株的增加。

局限性

  • 研究为单中心回顾性设计,仅覆盖冰岛一家医院。
  • 仅对部分分离株(2009-2014年间每隔一株)进行了全基因组测序。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The introduction of pneumococcal conjugate vaccines (PCVs) into childhood vaccination programs has reduced carriage of vaccine serotypes and pneumococcal disease. The 10-valent PCV was introduced in Iceland in 2011. The aim of this study was to determine PCV impact on the prevalence of serotypes, genetic lineages, and antimicrobial-resistant pneumococci isolated from the lower respiratory tract (LRT) of adults. Pneumococci isolated between 2009 and 2017 at the Landspitali University Hospital were included (n = 797). The hospital serves almost three-quarters of the Icelandic population. Isolates were serotyped and tested for antimicrobial susceptibility, and the genome of every other isolate collected between 2009 and 2014 was sequenced (n = 275). Serotypes and multilocus sequence types (STs) were extracted from the genome data. Three study periods were defined, 2009 to 2011 (PreVac), 2012 to 2014 (PostVac-I), and 2015 to 2017 (PostVac-II). The total number of isolates and vaccine-type (VT) pneumococci decreased from PreVac to PostVac-II (n = 314 versus n = 230 [p = 0.002] and n = 170 versus n = 33 [p < 0.001], respectively), but non-vaccine-type (NVT) pneumococci increased among adults 18 to 64 years old (n = 56 versus n = 114 [p = 0.008]). Serotype 19F decreased in the PostVac-II period; these isolates were all multidrug resistant (MDR) and were members of the Taiwan19F-14 PMEN lineage. Serotype 6A decreased among adults ≥65 years old in the PostVac-II period (p = 0.037), while serotype 6C increased (p = 0.021) and most serotype 6C isolates were MDR. Nonencapsulated Streptococcus pneumoniae (NESp) isolates increased among adults 18 to 64 years old in the PostVac-II period, and the majority were MDR (p = 0.028). An overall reduction in the number of LRT samples and pneumococcus-positive cultures and significant changes in the serotype distribution became evident within 4 years, thereby demonstrating a significant herd effect.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Quirk SJ, Haraldsson G, Hjálmarsdóttir MÁ, et al. Vaccination of Icelandic Children with the 10-Valent Pneumococcal Vaccine Leads to a Significant Herd Effect among Adults in Iceland. J Clin Microbiol. 2019. PMID: 30651396. doi:10.1128/JCM.01766-18

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。